UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 成人の肝硬変：合併症、全般的なマネージメント、予後の概要cirrhosis in adults overview of complications general management and prognosis [show details]
… may be associated with survival is the presence of relative adrenal insufficiency . In a study of 143 patients who were admitted to the hospital with decompensated cirrhosis, relative adrenal insufficiency …
2. 成人における腎移植：HLAマッチングと転帰kidney transplantation in adults hla matching and outcomes [show details]
… allograft survival may have diminished over the last several years, with nonimmunologic factors assuming more relative significance . In this study, the factors underlying allograft survival over the period …
3. 鎌状赤血球症のマネージメントおよび予後の概要overview of the management and prognosis of sickle cell disease [show details]
… recurrent acute chest syndrome, and death. Significant predictors of an adverse outcome included dactylitis before age one year (relative risk [RR] 2.6; 95% CI 1.39-4.67); hemoglobin concentration <7 g/dL (RR 2 …
4. 新規に診断された進行卵巣癌に対する術前補助化学療法に対する患者選択とアプローチpatient selection and approach to neoadjuvant chemotherapy for newly diagnosed advanced ovarian cancer [show details]
… groups (HR 1.02, 85% CI 0.92-1.13). NACT was, however, associated with lower postoperative mortality (relative risk 0.18, 95% CI 0.26-0.92). Rates of infection, need for stoma formation, and bowel resection …
5. 妊娠中絶の概要overview of pregnancy termination [show details]
… with an increased relative risk of preterm delivery, low birth weight, and small for gestational age (SGA) infants, although the absolute risk remained small . The reported outcomes were: (1) preterm birth …

Japanese Journal

国がんが5年相対生存率など最新がん統計

週刊保健衛生ニュース (2062), 45, 2020-06-08
NAID 40022245020

がんサバイバーの引受可能性の検討

鈴木麻衣子,徳丸初美,湯脇恵一,田端淳一,安達慶
日本保険医学会誌 = Japanese journal of insurance medicine 118(1), 29-34, 2020-03
NAID 40022195847

膵癌集学的治療:―長期生存を目指す最新知見―

田口昌延,山口博紀,佐田尚宏
膵臓 35(2), 193-200, 2020
… <p>膵癌の5年相対生存率は他の消化器癌と比較して著しく低く，膵癌は難治性癌の筆頭である．この疾患から長期生存を得る最良の方法は局所を根治切除し，術後に全身補助化学療法を行うこととされてきた．現在，膵癌のさらなる治療成績向上を目指し，術前治療が行われている．ここでは膵癌術後補助化学療法と術前治療について，最新の知見に基づいて解説する．JASPAC01試験からS-1による術後補助化学療法はわ …
NAID 130007871550